In patients with pancreatitis from CF and some remaining pancreatic function, treatment of some genetic variants in the cystic fibrosis transmembrane conductance regulator (CFTR) with CFTR modulators resulted in highly significantly improved lung function and weight gain in almost all patients.19 The gene discussed is CFTR; the disease is pancreatitis.